Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...

Elevance Health (ELV) stock rises as CFO cites underestimated Q1 profit forecasts from analysts for the company at Barclays ...

Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...

pharmacy benefit managers, and high drug prices to make health care more affordable for Hoosiers.” That political backdrop coincides with other challenges. Late last year, Elevance endured a ...

Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

Elevance Health (NYSE: ELV) presented at the Barclays ... identify members with care gaps and chronic risk factors. Our care management teams then perform proactive outreach to provide early ...

GreensKeeper Asset Management stated the following regarding Elevance Health, Inc. (NYSE ... utilizing the company's digital solutions to improve care quality for consumers.